[1] |
World Health Organization. Coronavirus disease (COVID-19) weekly epidemiological update and weekly operational update[EB/OL]. (2022-04-20)[2022-04-21].
URL
|
[2] |
World Health Organization. Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern[EB/OL]. (2021-11-26)[2022-04-22].
URL
|
[3] |
Seyit M, Avci E, Nar R, et al. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19[J]. Am J Emerg Med, 2021, 40: 110-114. DOI: 10.1016/j.ajem.2020.11.058.
|
[4] |
|
[5] |
Islamoglu MS, Borku-Uysal B, Yavuzer S, et al. The diagnostic and predictive roles of neutrophil-lymphocyte ratio for severity of disease in COVID-19 patients[J]. Clin Lab, 2021, 67(12). DOI: 10.7754/Clin.Lab.2021.210449.
|
[6] |
Zhu R, Chen C, Wang Q, et al. Routine blood parameters are helpful for early identification of influenza infection in children[J]. BMC Infect Dis, 2020, 20(1): 864. DOI: 10.1186/s12879-020-05584-5.
|
[7] |
Kalabin A, Mani VRK, Valdivieso SC, et al. Role of neutrophil-to-lymphocyte, lymphocyte-to-monocyte and platelet-to-lymphocyte ratios as predictors of disease severity in COVID-19 patients[J]. Infez Med, 2021, 29(1): 46-53.
|
[8] |
国家卫生健康委员会办公厅,国家中医药管理局办公室. 新型冠状病毒肺炎诊疗方案(试行第九版)[EB/OL]. (2022-03-15)[2022-04-20].
URL
|
[9] |
国家卫生健康委员会办公厅. 新型冠状病毒肺炎防控方案(第五版).新型冠状病毒肺炎实验室检测技术指南[EB/OL]. (2020-02-21)[2022-04-20].
URL
|
[10] |
Lu X, Zhang L, Du H, et al. SARSCoV2 infection in children[J]. N Engl J Med, 2020, 382(17): 16631665. DOI: 10.1056/NEJMc2005073.
|
[11] |
|
[12] |
Liguoro I, Pilotto C, Bonanni M, et al. SARS-COV-2 infection in children and newborns: a systematic review[J]. Eur J Pediatr, 2020, 179(7): 1029-1046. DOI: 10.1007/s00431-020-03684-7.
|
[13] |
Ciccullo A, Borghetti A, Zileri Dal Verme L, et al. Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line[J]. Int J Antimicrob Agents, 2020, 56(2): 106017. DOI: 10.1016/j.ijantimicag.2020.106017.
|
[14] |
Erdogan T. Role of systemic immune-inflammation index in asthma and NSAID-exacerbated respiratory disease[J]. Clin Respir J, 2021, 15(4): 400-405. DOI: 10.1111/crj.13314.
|
[15] |
Andrews N, Stowe J, Kirsebom F, et al. Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England[J]. Nat Med, 2022, 28(4): 831-837. DOI: 10.1038/s41591-022-01699-1.
|
[16] |
Liu L, Zheng Y, Cai L, et al. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19[J]. Int J Lab Hematol, 2021, 43(2): 329-335. DOI: 10.1111/ijlh.13374..
|
[17] |
Shahid MF, Malik A, Siddiqi FA, et al. Neutrophil-to-lymphocyte ratio and absolute lymphocyte count as early diagnostic tools for corona virus disease 2019[J]. Cureus, 2022, 14(3): e22863. DOI: 10.7759/cureus.22863.
|
[18] |
Bg S, Gosavi S, Ananda Rao A, et al. Neutrophil-to-lymphocyte, lymphocyte-to-monocyte, and platelet-to-lymphocyte ratios: prognostic significance in COVID-19[J]. Cureus, 2021, 13(1): e12622. DOI: 10.7759/cureus.12622.
|
[19] |
Yildiz E, Cigri E, Dincer Z, et al. High neutrophil/lymphocyte ratios in symptomatic pediatric COVID-19 patients[J]. J Coll Physicians Surg Pak, 2021, 31(7): S93-S98. DOI: 10.29271/jcpsp.2021.
|
[20] |
Anderson R, Feldman C. Review manuscript: mechanisms of platelet activation by the pneumococcus and the role of platelets in community-acquired pneumonia[J]. J Infect, 2017, 75(6): 473-485. DOI: 10.1016/j.jinf.2017.09.013.
|
[21] |
Hirahara T, Arigami T, Yanagita S, et al. Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer[J]. BMC Cancer, 2019, 19(1): 672. DOI: 10.1186/s12885-019-5903-y.
|
[22] |
Eissa M, Shaarawy S, Abdellateif MS, et al. The role of different inflammatory indices in the diagnosis of COVID-19[J]. Int J Gen Med, 2021, 14: 7843-7853. DOI: 10.2147/IJGM.S337488.
|
[23] |
Fleming-Dutra KE, Britton A, Shang N, et al. Association of prior BNT162b2 COVID-19 vaccination with symptomatic SARS-CoV-2 infection in children and adolescents during omicron predominance[J]. JAMA, 2022, 327(22): 2210-2219. DOI: 10.1001/jama.2022.7493.
|
[24] |
Bar-ON YM, Goldberg Y, Mandel M, et al. Protection of BNT162b2 vaccine booster against COVID-19 in Israel[J]. N Engl J Med, 2021, 385(15): 1393-1400. DOI: 10.1056/NEJMoa2114255.
|
[25] |
简丽娟,姚向阳,伍定辉. 新冠肺炎患者核酸转阴时间延长的影响因素分析[J]. 海峡预防医学杂志,2022, 28(3): 14-17.
|
[26] |
|
[27] |
|